These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 8441831)

  • 21. The use of pharmacokinetics as an interpretive and predictive tool in chemical toxicology testing and risk assessment: a position paper on the appropriate use of pharmacokinetics in chemical toxicology.
    Frantz SW; Beatty PW; English JC; Hundley SG; Wilson AG
    Regul Toxicol Pharmacol; 1994 Jun; 19(3):317-37. PubMed ID: 8090955
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Implications of recommendations from the International Conference on Harmonization (ICH) for the safety evaluation of new medicines involving animal studies for the pharmaceutical industry.
    Scales MD
    Adverse Drug React Toxicol Rev; 1992; 11(1):5-12. PubMed ID: 1606283
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predictive value of preclinical toxicology studies for platinum anticancer drugs.
    Clark DL; Andrews PA; Smith DD; DeGeorge JJ; Justice RL; Beitz JG
    Clin Cancer Res; 1999 May; 5(5):1161-7. PubMed ID: 10353752
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vivo erythrocyte micronucleus assay III. Validation and regulatory acceptance of automated scoring and the use of rat peripheral blood reticulocytes, with discussion of non-hematopoietic target cells and a single dose-level limit test.
    Hayashi M; MacGregor JT; Gatehouse DG; Blakey DH; Dertinger SD; Abramsson-Zetterberg L; Krishna G; Morita T; Russo A; Asano N; Suzuki H; Ohyama W; Gibson D;
    Mutat Res; 2007 Feb; 627(1):10-30. PubMed ID: 17157053
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A rational approach to risk assessment requires the use of biological information: an analysis of the National Toxicology Program (NTP), final report of the advisory review by the NTP Board of Scientific Counselors.
    Goodman JI
    Regul Toxicol Pharmacol; 1994 Feb; 19(1):51-9. PubMed ID: 8159815
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Toxicity testing in the 21st century: bringing the vision to life.
    Andersen ME; Krewski D
    Toxicol Sci; 2009 Feb; 107(2):324-30. PubMed ID: 19074763
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The minipig in toxicology.
    Svendsen O
    Exp Toxicol Pathol; 2006 Jul; 57(5-6):335-9. PubMed ID: 16725317
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Precision of estimates of an ADI (or TDI or PTWI).
    Speijers GJ
    Regul Toxicol Pharmacol; 1999 Oct; 30(2 Pt 2):S87-93. PubMed ID: 10597619
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Strengths and limitations of using repeat-dose toxicity studies to predict effects on fertility.
    Dent MP
    Regul Toxicol Pharmacol; 2007 Aug; 48(3):241-58. PubMed ID: 17512650
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chronic toxicity and carcinogenicity guidelines.
    Page NP
    J Environ Pathol Toxicol; 1977; 1(2):161-82. PubMed ID: 553129
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Animal toxicology for early clinical trials with anticancer agents.
    Rozencweig M; Von Hoff DD; Staquet MJ; Schein PS; Penta JS; Goldin A; Muggia FM; Freireich EJ; DeVita VT
    Cancer Clin Trials; 1981; 4(1):21-8. PubMed ID: 6783332
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prediction and classification of drug toxicity using probabilistic modeling of temporal metabolic data: the consortium on metabonomic toxicology screening approach.
    Ebbels TM; Keun HC; Beckonert OP; Bollard ME; Lindon JC; Holmes E; Nicholson JK
    J Proteome Res; 2007 Nov; 6(11):4407-22. PubMed ID: 17915905
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of rodent-only toxicology for early clinical trials with novel cancer therapeutics.
    Newell DR; Burtles SS; Fox BW; Jodrell DI; Connors TA
    Br J Cancer; 1999 Nov; 81(5):760-8. PubMed ID: 10555743
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proposal for international guidelines for reproductive and developmental toxicity testing for pharmaceuticals.
    Lumley CE
    Adverse Drug React Toxicol Rev; 1991; 10(3):143-53. PubMed ID: 1747441
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Testing strategies in mutagenicity and genetic toxicology: an appraisal of the guidelines of the European Scientific Committee for Cosmetics and Non-Food Products for the evaluation of hair dyes.
    Kirkland DJ; Henderson L; Marzin D; Müller L; Parry JM; Speit G; Tweats DJ; Williams GM
    Mutat Res; 2005 Dec; 588(2):88-105. PubMed ID: 16326131
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics and toxicity testing.
    Clark B; Smith DA
    Crit Rev Toxicol; 1984; 12(4):343-85. PubMed ID: 6378530
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comments on the assessment of neurotoxicity in routine toxicity studies.
    Schaeppi U
    Zentralbl Bakteriol Mikrobiol Hyg B Umwelthyg Krankenhaushyg Arbeitshyg Prav Med; 1987 Oct; 185(1-2):65-8. PubMed ID: 3124391
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A proposed design for conducting target animal safety studies for developing new veterinary pharmaceuticals.
    Carakostas MC; Colaianne JJ
    Regul Toxicol Pharmacol; 1996 Feb; 23(1 Pt 1):49-54. PubMed ID: 8628920
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Strategy for genotoxicity testing: hazard identification and risk assessment in relation to in vitro testing.
    Thybaud V; Aardema M; Clements J; Dearfield K; Galloway S; Hayashi M; Jacobson-Kram D; Kirkland D; MacGregor JT; Marzin D; Ohyama W; Schuler M; Suzuki H; Zeiger E;
    Mutat Res; 2007 Feb; 627(1):41-58. PubMed ID: 17126066
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Juvenile animal testing in drug development--is it useful?
    Baldrick P
    Regul Toxicol Pharmacol; 2010; 57(2-3):291-9. PubMed ID: 20350578
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.